Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy

Thromb Res. 2021 Jan:197:202-204. doi: 10.1016/j.thromres.2020.10.038. Epub 2020 Nov 6.

Abstract

  1. -

    We report a translational experience of a cardiovascular department facing MACE in COVID-19 patients.

  2. -

    Acute arterial events are the real emergency into this COVID-19 pandemic.

  3. -

    COVID-19 infection may trigger a hypercoagulable status leading to MACE and high mortality rate.

  4. -

    In this COVID-19 outbreak, the adjunct of heparin provides better survival chance independently of the infection-related drug treatment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants
  • COVID-19*
  • Cardiovascular Diseases* / epidemiology
  • Humans
  • Italy / epidemiology
  • SARS-CoV-2

Substances

  • Anticoagulants